These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29179444)

  • 21. UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis.
    Wang B; Shen J; Wang J
    Onco Targets Ther; 2017; 10():5303-5309. PubMed ID: 29158682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of NF-κB and hypoxia on the biological behavior of Y79 retinoblastoma cells.
    Li P; Li Z
    Int J Clin Exp Pathol; 2015; 8(2):1725-30. PubMed ID: 25973060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
    Hidalgo M; Rowinsky EK
    Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
    Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
    Bielecki A; Roberts J; Mehta R; Raju J
    Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
    Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways.
    Sun YW; Huang WJ; Hsiao CJ; Chen YC; Lu PH; Guh JH
    Prostate; 2010 Sep; 70(12):1295-306. PubMed ID: 20623631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinoline-Based Compound BPIQ Exerts Anti-Proliferative Effects on Human Retinoblastoma Cells via Modulating Intracellular Reactive Oxygen Species.
    Cheng KC; Hung CT; Chen KJ; Wu WC; Suen JL; Chang CH; Lu CY; Tseng CH; Chen YL; Chiu CC
    Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):139-47. PubMed ID: 26564153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
    Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
    Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.
    Sreenivasan S; Thirumalai K; Danda R; Krishnakumar S
    Curr Eye Res; 2012 May; 37(5):421-8. PubMed ID: 22510010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway.
    Zhang Y; Mao L; Jiang A; Liu J; Lu Y; Yao C; Huang G
    Exp Eye Res; 2024 Oct; 247():110040. PubMed ID: 39134132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
    Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
    Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erlotinib has tumor inhibitory effect in human retinoblastoma cells.
    Shao Y; Yu Y; Zong R; Quyang L; He H; Zhou Q; Pei C
    Biomed Pharmacother; 2017 Jan; 85():479-485. PubMed ID: 27899256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
    Xing L; Zhang L; Feng Y; Cui Z; Ding L
    Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.
    J Exp Clin Cancer Res; ; . PubMed ID: 26940018
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.